Brain Cancer Awareness Month

Written By Erica Stupfel

Groundbreaking Glioblastoma Treatment

In honor of Brain Cancer Awareness Month, we’re highlighting NEO100, a groundbreaking glioblastoma treatment that, with your support, is now accessible to CARE patients through a single patient IND study.

Currently in a Phase 2 clinical trial, NEO100 is showing promising results for treating glioblastoma, an aggressive Stage IV brain cancer. Early studies show the intranasal drug is well tolerated and correlates with improved survival.

We look forward to sharing heartening patient updates and are grateful for your support in bringing life-changing treatments like NEO100 to members of our community.

Learn more: NEO100 Brings Hope to Glioblastoma Patients

Erica Stupfel

e*design Creative Services specializes in making professional design available to small companies and individuals. I understand the importance in brand identity and how a positive visual representation of your product or service can make the difference between success and failure. Your ideas and vision combined with my marketing and design expertise will be a sure success story.

https://www.edesigncreative.com
Previous

Words of Hope
Next

Clinical Trials 101: How to Get Started